Despite reducing amyloid plaques, antibody treatments for Alzheimer's fail to improve cognition, highlighting critical gaps ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced additional positive results from the pivotal study of zilganersen in children and adults living with Alexander disease (AxD), a rare, ...
YouTube on MSN
My lifelong strategy to outsmart Alzheimer’s
Alzheimer’s starts decades before symptoms. Learn about my #1 brain nutrient—and how you can take simple, science-backed ...
Alzheimer's disease drug research is moving beyond symptom relief. This article explores anti-amyloid antibodies, safer ...
As people live longer, age-related disorders, including many neurodegenerative diseases, are becoming increasingly common.
In a large ASPREE and ASPREE-XT nested case-control study of older adults without prior cardiovascular disease, people who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results